Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LMDXW
- Price
- -
- Stock movement down
- -0.00 (-36.92%)
- Company name
- LumiraDx Limited Warrant
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- -
- Ent value
- 530.21M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -99.45%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
LMDXW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | 3.65 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -1.25 |
| FCF per share (TTM) | -0.46 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 145.46M |
| Gross profit (TTM) | -198.86M |
| Operating income (TTM) | -409.58M |
| Net income (TTM) | -397.56M |
| EPS (TTM) | -1.25 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -136.71% |
| Operating margin (TTM) | -281.57% |
| Profit margin (TTM) | -273.31% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 25.34M |
| Net receivables | 64.78M |
| Total current assets | 175.31M |
| Goodwill | 14.96M |
| Intangible assets | 17.37M |
| Property, plant and equipment | 120.86M |
| Total assets | 340.83M |
| Accounts payable | 65.99M |
| Short/Current long term debt | 402.76M |
| Total current liabilities | 89.00M |
| Total liabilities | 555.55M |
| Shareholder's equity | -214.73M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -136.54M |
| Capital expenditures (TTM) | 11.45M |
| Free cash flow (TTM) | -147.99M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -116.65% |
| Return on Invested Capital | -238.82% |
| Cash Return on Invested Capital | -88.90% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| LMDXW | S&P500 | |
| Current price drop from All-time high | -99.80% | -0.65% |
| Highest price drop | -99.80% | -56.47% |
| Date of highest drop | 8 Jan 2024 | 9 Mar 2009 |
| Avg drop from high | -68.22% | -10.99% |
| Avg time to new high | 32 days | 12 days |
| Max time to new high | 408 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.
Employees
1210
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner